Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 10/20 | 0.49 |
| ▸ | CRBN | Q96SW2 | 10/20 | 0.49 |
| ▸ | IKZF2 | Q9UKS7 | 8/20 | 0.40 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30289048 | 0.89 | DDB1 (0.47) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL31323566 | 0.89 | DDB1 (0.51) | DDB1CRBNIKZF2IKZF1HDAC8 | |
| SCHEMBL22502565 | 0.89 | DDB1 (0.50) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL23540861 | 0.89 | DDB1 (0.52) | DDB1CRBNIKZF2IKZF1HDAC8 | |
| SCHEMBL23541289 | 0.89 | DDB1 (0.52) | DDB1CRBNIKZF2IKZF1HDAC8 | |
| SCHEMBL31333960 | 0.88 | DDB1 (0.54) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL30288962 | 0.88 | DDB1 (0.49) | DDB1CRBNIKZF2IKZF1 | |
| SCHEMBL22525513 | 0.88 | DDB1 (0.49) | DDB1CRBNIKZF2IKZF1HDAC8 | |
| SCHEMBL30289409 | 0.87 | DDB1 (0.44) | DDB1CRBNIKZF2IKZF1HDAC8 | |
| SCHEMBL23540374 | 0.87 | DDB1 (0.50) | DDB1CRBNIKZF2IKZF1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709720-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | Larkspur Biosciences, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024233846-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | LARKSPUR BIOSCIENCES, INC. (US) | 2024-11-14 | — | — | WO | disclosed |